Historic Executive Order: Federal Ibogaine Research for Veterans
President Trump signs landmark directive directing $50M+ in federal funding to accelerate ibogaine clinical development for veterans with PTSD and TBI.
Read More →
Articles
Articles & insights
Explainers we have written for people who want the detail rather than the headline: what the Stanford results did and did not show, how iboga travelled from ritual use in Gabon to clinics in Mexico and Portugal, why blast-related brain injury behaves differently from psychological trauma alone, what GDNF stimulation might mean for neurodegenerative disease, and the regulatory argument for a supervised access pathway in Israel. Each piece cites its sources so you can check the reasoning for yourself.
Last reviewed:
Latest
Articles & Insights
Ibogaine — The Deadly Psychedelic That May Beat Addiction
Ynet's Dr. Roy Zucker examines ibogaine's extraordinary promise for addiction and PTSD — and the cardiac risks and regulatory hurdles that keep Big Pharma at bay. Plus: the Israeli firm PsyRx taking a safer microdose path.
Read More →
Stanford's Landmark Study: Ibogaine Reduces PTSD by 88% in Veterans
A peer-reviewed study published in Nature Medicine confirms ibogaine's extraordinary efficacy for traumatic brain injury and PTSD. Here's what it means for Israel.
Read More →
From Gabon to the Clinic: The Remarkable History of Ibogaine
The iboga plant has been sacred to Bwiti communities for centuries. We trace the journey from Central African rainforests to modern psychiatric clinics.
Read More →
October 7 and After: Israel's Mental Health Crisis Demands Bold Solutions
With 85,000 soldiers receiving psychological treatment and therapist shortages reaching crisis levels, conventional approaches are falling short.
Read More →
Can Ibogaine Help Parkinson's Patients? Early Evidence Is Promising
Ibogaine's ability to stimulate GDNF — a key neurotrophic factor for dopamine neurons — is opening new possibilities for neurodegenerative disease treatment.
Read More →Israel Needs Ibogaine: The Case for Fast-Tracking Regulatory Approval
As Texas allocates $50 million for ibogaine clinical trials, Israel must move swiftly to ensure its trauma survivors have access to the world's most promising new therapy.
Read More →
Howard Lotsof's Gift: The Discovery That Changed Everything
In 1962, a 19-year-old heroin addict named Howard Lotsof took ibogaine and woke up free. His life's work created the global ibogaine treatment movement.
Read More →Help make ibogaine therapy available in Israel
Add your name to the public petition, or contact us about research collaboration, clinical partnership, volunteering, or media enquiries. We reply to every message.